Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 20/20 | 0.54 |
| ▸ | CHRM3 | P20309 | 20/20 | 0.54 |
| ▸ | CHRM5 | P08912 | 19/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16292695 | 0.83 | CHRM1 (0.54) | CHRM1CHRM3CHRM5CHRM2 | |
| SCHEMBL28541412 | 0.75 | CHRM1 (0.41) | CHRM1CHRM3CHRM5CHRM2 | |
| SCHEMBL28909842 | 0.73 | CHRM1 (0.71) | CHRM1CHRM3CHRM5CHRM2 | |
| SCHEMBL31286989 | 0.71 | LMNA (0.47) | — | |
| SCHEMBL870071 | 0.71 | CHRM5 (0.47) | CHRM1CHRM3CHRM5CHRM2 | |
| SCHEMBL28540751 | 0.70 | CHRM1 (0.74) | CHRM1CHRM3CHRM5CHRM2 | |
| SCHEMBL12206727 | 0.70 | CHRM1 (0.44) | CHRM1CHRM3CHRM5CHRM2 | |
| SCHEMBL16292414 | 0.68 | CHRM5 (0.54) | CHRM1CHRM3CHRM5CHRM2 | |
| SCHEMBL16006988 | 0.67 | CHRM3 (0.39) | CHRM1CHRM3CHRM5CHRM2 | |
| SCHEMBL16293284 | 0.67 | CHRM5 (0.55) | CHRM1CHRM3CHRM5CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115427038-A | Methods of treating nervous system symptoms associated with lysosomal storage diseases | 建新公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-114040762-A | Treatment of ciliary disease using inhibitors of glucosylceramide synthase (GCS) | 建新公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-113710249-A | Methods for treating symptoms and disorders associated with lysosomal storage disorders | 建新公司 | 2021-11-26 | — | — | CN | disclosed |
| CN-113645969-A | Methods for treating symptoms and disorders associated with lysosomal storage disorders | 建新公司 | 2021-11-12 | — | — | CN | disclosed |